Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. No cytogenetic data were reported.

類似資料

• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women.
  著者:: Christiansen, O. B.
  出版事項: (1997)
• Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
  著者:: Rai, R., 等
  出版事項: (1997)
• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery.
  著者:: Piette, J. C., 等
  出版事項: (1997)
• Cytogenetic Analysis of Patients with Recurrent Miscarriages
  著者:: Muhammad Umar, 等
  出版事項: (2023-04-01)
• Cytogenetic investigation of couples with recurrent spontaneous miscarriages
  著者:: Hanif, Misbah Iqbal, 等
  出版事項: (2019)